2025 SPS Minneapolis | Tarlatamab in Neuroendocrine Tumors:  Clinical Implications & Challenges of Antibody Drug Conjugates

2025 SPS Minneapolis | Tarlatamab in Neuroendocrine Tumors: Clinical Implications & Challenges of Antibody Drug Conjugates

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Sep 13, 2025
Last Review
Sep 13, 2025
Expires
Sep 13, 2026

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Marie Parish, PharmD, BCOP

Disclosure

Marie Parish, PharmD, BCOP

Accreditation

NA